TY - CHAP
T1 - Diabetic retinopathy screening in the WHO European Region: plans for development, barriers and facilitators: A survey of professional associations and key informants Preliminary findings for consultation
AU - Broadbent, Deborah M.
AU - Cohen, Sue
AU - Curran, Katie
AU - Harding, Prof Simon P.
AU - Peto, Tunde
AU - Vazquez-Arango, Pilar
AU - Losada, Maria Lasierra
AU - Farrington, Jill
AU - Berdzuli, Nino
PY - 2021/10/29
Y1 - 2021/10/29
N2 - WHO recommends diabetic retinopathy (DR) screening for all people with diabetes and treatment for prevention of blindness as an effective intervention in tackling a major noncommunicable disease. The WHO Regional Office for Europe commissioned the University of Liverpool, United Kingdom, to produce a situational analysis of DR screening provision and capacity plans across Member States of the WHO European Region. The purpose of the situational analysis is to describe the current status, plans for development, and barriers and facilitators to progress of DR screening in the WHO European Region by seeking the perspectives of ophthalmology and endocrinology professional organizations in Member States. Information was collected using a survey tool. Respondents from 45 of the 53 Member States returned surveys. The findings are presented in two reports: the first, published in early 2021 by the WHO Regional Office for Europe, covered the current situation. This second report presents preliminary findings for consultation on plans for development, barriers and facilitators. The situational analysis demonstrates that there is much that countries in the WHO European Region can do to improve the effectiveness of DR screening. By acting, they may reduce the burden of vision impairment and blindness due to DR in their countries.
AB - WHO recommends diabetic retinopathy (DR) screening for all people with diabetes and treatment for prevention of blindness as an effective intervention in tackling a major noncommunicable disease. The WHO Regional Office for Europe commissioned the University of Liverpool, United Kingdom, to produce a situational analysis of DR screening provision and capacity plans across Member States of the WHO European Region. The purpose of the situational analysis is to describe the current status, plans for development, and barriers and facilitators to progress of DR screening in the WHO European Region by seeking the perspectives of ophthalmology and endocrinology professional organizations in Member States. Information was collected using a survey tool. Respondents from 45 of the 53 Member States returned surveys. The findings are presented in two reports: the first, published in early 2021 by the WHO Regional Office for Europe, covered the current situation. This second report presents preliminary findings for consultation on plans for development, barriers and facilitators. The situational analysis demonstrates that there is much that countries in the WHO European Region can do to improve the effectiveness of DR screening. By acting, they may reduce the burden of vision impairment and blindness due to DR in their countries.
UR - https://www.euro.who.int/en/health-topics/noncommunicable-diseases/diabetes/activities/diabetic-retinopathy-screening/diabetic-retinopathy-screening-in-the-who-european-region-plans-for-development,-barriers-and-facilitators-2021
M3 - Chapter
SP - 1
BT - Diabetic retinopathy screening in the WHO European Region: plans for development, barriers and facilitators (2021)
PB - World Health Organization
ER -
